44
PERFORMANCE MEASURES 2017 State of C.O.R.E.

2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

  • Upload
    others

  • View
    0

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

PERFORMANCE MEASURES

2017 State of C.O.R.E.

Page 2: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

C.O.R.E. Mission Statement

Comprehensive Opiate Recovery Experience

RECOVERY WITH RESPECT

“Improving the lives of individuals through comprehensive opiate replacement services”

Page 3: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

C.O.R.E. medical clinic is dedicated to maximizing patient outcomes by:

Helping each patient attain and maintain his/her highest quality of life

Treating opiate addiction with medically assisted treatment, group counseling, individual counseling, and case management services

Diagnosing, treating, and/or referring mental health disorders

Diagnosing, treating, and/or referring co-morbid medical problems

Reducing harm and stigma related to illicit drug use through education, counseling, and treatment

Educating our staff, patients, and the community on evidence-based drug treatment strategies and policies

Treating each patient with respect and dignity

Page 4: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

C.O.R.E. medical clinic is dedicated to maximizing patient outcomes by:

Providing person- and family-centered services based on strengths, needs, abilities, preferences, and desired outcomes of the patient and family

Including the patient in the treatment planning process

Being ever vigilant to the risk of bias

Working on personal growth

Striving to treat all patients equally regardless of gender, race, ethnicity, cultural, religion, age, sexual preference, or related factors

Creating a positive and safe work environment for staff

Being sensitive to social and cultural factors that influence the patient (i.e. cultural competence)

Page 5: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Census by Month

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

MMP 675 675 673 684 698 702 712 706 710 715 711 709

LTD 0 0 0 0 0 0 0 0 0 1 1 2

MSW 3 4 4 5 0 2 1 0 0 1 0 1

400

500

600

700

MMP

LTD

MSW

Page 6: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2012 – 2017 Average Dose

7/1/2012 = 88.5 mg

7/1/2013 = 87.7 mg

7/1/2014 = 86.87 mg

7/1/2015 = 86.73 mg

7/1/2016 = 81.53 mg

7/1/2017 = 80.02 mg

Page 7: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Site Demographics by Gender & Funding

1/1/2017 12/31/2017

51% Male 50% Male

49% Female 50% Female

55.07% Medi-Cal 47.42% Medi-Cal

13.95% Private Pay 12.55% Private Pay

30.98% Other 40.03% Other

Page 8: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Site Demographics Comparison

1/1/2017 12/31/2017

61.23% Caucasian 58.86% Caucasian

18.36% Hispanic 19.53% Hispanic

10.57% African-American 10.74% African-American

1.76% Asian 2.09% Asian

1.32% American Indian 1.53% American Indian

6.76% Other 7.25% Other

Page 9: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Site Demographics Comparison by Age

1/1/2017 12/31/2017

18-24 2.21% 18-24 2.23%

25-34 21.58% 25-34 22.03%

35-44 20.56% 35-44 21.19%

45-54 17.48% 45-54 16.04%

55-69 34.36% 55-69 34.45%

70+ 3.37% 70+ 3.35%

Page 10: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 UA by Month

Page 11: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 UA by Month

Page 12: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 TB Tests

557

115

2

674 TB Tests

Negative

Negative SymptomsScreen

Positive

Page 13: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Discharge reasons - ALL

27

73

44

11

1

1411

06

23

12.8

6%

34.7

6%

20.9

5%

5.24

%

0.48

%

6.67

%

5.24

%

0.00

%

2.86

%

10.9

5%

01020304050607080

Discharges

Percent

Page 14: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Pregnancy Data

Deliveries = 13

Average Weight = 7 lbs 1 oz

Average Height = 19.6 inches

Average Dose at Delivery = 62

% Babies on Meds = 39%

Average Weeks Pregnant = 38

Average Days Baby Stayed in Hospital = 18

Negative Drug Screens at Delivery = 70%

Page 15: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Total Number of PODS

Page 16: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 PODS by Gender

Page 17: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Average Age by Time in Treatment

Page 18: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 SSI/SDI

Page 19: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Education

Page 20: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Abuse & Misuse of Rx Drugs

Page 21: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Chronic Conditions

Page 22: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Probation/Parole

Page 23: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Emergency Room Visits

Page 24: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Hepatitis C

Page 25: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Primary Health Care Provider

Page 26: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Mental Health

Page 27: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Mental Health Provider

Page 28: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 California Outcomes Measures System (CalOMS) Data

DISCHARGE DATA Patients left with satisfactory progress = 85%

ANNUAL UPDATE DATA Patients that used primary drug of choice in last 30

days = 10%

Patients that used secondary drug of choice in last 30 days = 16%

Patients that were arrested in last 30 days = <1%

Patients that spent days in jail and/or prison in the last 30 days = <1%

Page 29: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

ANNUAL UPDATE DATA Patients that visited emergency room in last 30

days = 2%

Patients that received emergency outpatient services for mental health in last 30 days = 3%

Patients that stayed over 24 hours in a hospital or psych facility for mental health needs in last 30 days = 1%

Patients that identified as homeless = 1%

2017 California Outcomes Measures System (CalOMS) Data

Page 30: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Patient Survey

74.00%

15.00%

2.00% 1.50% 1.00%6.00%

0.0%

20.0%

40.0%

60.0%

80.0%

100.0%

Always Usually Sometimes Seldom Never Left Blank

Do you feel your cultural, spiritual, and personal values, beliefs, and preferences

are respected?

Page 31: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

19

1 0 0 0 00

5

10

15

20

VerySatisfied

SomewhatSatisfied

NeitherSatisfied norDissatisfied

SomewhatDissatisfied

Dissatisfied Blank

A1: Overall, how satisfied are you with your job?

Page 32: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

11

2

4

10

2

0

2

4

6

8

10

12

VerySatisfied

SomewhatSatisfied

NeitherSatisfied norDissatisfied

SomewhatDissatisfied

Dissatisfied Blank

A2: Compared with a year ago, how would you describe your current job

satisfaction?

Page 33: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

14

5

10 0 0

02468

10121416

StronglyAgree

SomewhatAgree

NeitherAgree norDisagree

SomewhatDisagree

StronglyDisagree

Blank

B1: Company leadership has made changes which are positive for me.

Page 34: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

16

4

0 0 0 002468

1012141618

StronglyAgree

SomewhatAgree

NeitherAgree norDisagree

SomewhatDisagree

StronglyDisagree

Blank

B2: Company leadership is responding to important external issues.

Page 35: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

14

6

0 0 0 002468

10121416

StronglyAgree

SomewhatAgree

NeitherAgree norDisagree

SomewhatDisagree

StronglyDisagree

Blank

B3: Company leadership is responding to important internal issues.

Page 36: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

13

5

2

0 0 00

2

4

6

8

10

12

14

StronglyAgree

SomewhatAgree

NeitherAgree norDisagree

SomewhatDisagree

StronglyDisagree

Blank

B4: I am enthusiastic about the change in the company.

Page 37: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

18

1 0 0 0 1

0

5

10

15

20

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C1: Are you satisfied that the leaders in your work environment are positive role

models?

Page 38: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

12

7

0 0 01

0

2

4

6

8

10

12

14

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C2: Are you satisfied that your views and participation are valued?

Page 39: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

14

5

0 0 01

0

5

10

15

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C3: Are you satisfied with the morale and team work of your work

environment?

Page 40: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

13

5

10 0

1

0

2

4

6

8

10

12

14

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C4: Are you satisfied with the professionalism of the people with

whom you work?

Page 41: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

18

1 0 0 0 1

0

5

10

15

20

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C5: Are you satisfied that your work gives you a feeling of personal

accomplishment?

Page 42: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

13

4

10

1 1

0

2

4

6

8

10

12

14

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C6: Are you satisfied that you receive appropriate recognition for your

contributions?

Page 43: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

18

1 0 0 0 1

0

5

10

15

20

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C7: Are you satisfied with your ability to maintain a reasonable balance between your personal life and your work life?

Page 44: 2017 State of COREcoremedicalclinic.com/outcomes/2017SOC.pdf · 7/1/2016 = 81.53 mg 7/1/2017 = 80.02 mg. 2017 Site Demographics by Gender & Funding 1/1/2017 12/31/2017 51% Male 50%

2017 Workplace Survey

17

20 0 0

1

02468

1012141618

VerySatisfied

SomewhatSatisfied

Not Sure SomewhatDissatisfied

Dissatisfied Blank

C8: Are you satisfied with the company as a place to work?